Loading…
Pluri Inc. is projected to rise to $1.58 by 2027, a 0% move from its current price of $1.58. PLUR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.52 | $1.57 | $1.63 | -0.03% |
| Aug 6 | $1.50 | $1.57 | $1.66 | -0.06% |
| Aug 7 | $1.48 | $1.57 | $1.67 | -0.08% |
| Aug 8 | $1.47 | $1.57 | $1.69 | -0.11% |
| Aug 9 | $1.45 | $1.57 | $1.70 | -0.14% |
| Aug 10 | $1.44 | $1.57 | $1.72 | -0.17% |
| Aug 11 | $1.43 | $1.57 | $1.73 | -0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.43 | $1.57 | $1.73 | -0.20% |
| Week 2 | $1.37 | $1.57 | $1.79 | -0.39% |
| Week 3 | $1.33 | $1.57 | $1.84 | -0.59% |
| Week 4 | $1.29 | $1.56 | $1.89 | -0.79% |
| Week 5 | $1.26 | $1.56 | $1.93 | -0.98% |
| Week 6 | $1.24 | $1.56 | $1.96 | -1.18% |
| Week 7 | $1.21 | $1.55 | $1.99 | -1.37% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pluri Inc. is a biotechnology company based in Haifa, Israel, focused on the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. It operates across the fields of regenerative medicine, food tech, immunotherapy, CDMO, and AgTech.
The company develops placenta-based cell therapy product candidates for inflammatory conditions, muscle injuries, and hematologic issues, and maintains an immunotherapy platform. Its lead candidates include PLX-PAD, composed of maternal mesenchymal stromal cells originating from the placenta, and PLX-R18, composed of fetal MSC-like cells originating from the placenta; it also pursues an allogeneic MAIT cell therapy platform.
Pluri also offers cell manufacturing services and cell-based coffee, and it develops cultivated meat products. It has a collaboration with Bar-Ilan University to advance cancer immunotherapy for solid tumors. The company was formerly known as Pluristem Therapeutics Inc.
and changed its name to Pluri Inc. in July 2022, and it was incorporated in 2001. It is based in Haifa, Israel.
Pluri Inc. (PLUR) is a biotechnology company focused on cell-based products and related technologies for multiple industries. The stock trades at $1.64 per share and has a market cap of $17.69M, with a market rank of 4733.
The near-term technical picture shows neutral sentiment, with RSI14 at 30, SMA50 at $2.22 and SMA200 at $3.17. Support is at $1.63 and resistance at $2.33; the thirty-day price range runs from $1.26 to $2.13.
Longer-term forecasts imply potential upside over the coming years, with the 2026 average at $1.64 and a 2026 max of $2.08, and a bullish trajectory emerging from 2031 onward. The 2030 average is $1.96 with a max of $3.11 and ROI of 19.6%, followed by higher averages and bullish sentiment through 2031–2033, then substantial upside into 2040 and 2050 (2040 avg $2.74, ROI 67.1%; 2050 avg $5.04, ROI 207.2%), with a max of $10.89.
A major floor 28.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.6% away) — a key level to hold.
The nearest ceiling, 38.4% above — a clean break opens room to run.
A major ceiling 129.8% above — clearing it would confirm fresh momentum.
Key PLUR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PLUR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.60 | Sell | $1.61 | Sell |
| MA 10 | $1.72 | Sell | $1.68 | Sell |
| MA 20 | $1.78 | Sell | $1.79 | Sell |
| MA 50 | $2.07 | Sell | $2.12 | Sell |
| MA 100 | $2.70 | Sell | $2.53 | Sell |
| MA 200 | $3.11 | Sell | $3.06 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.85 | Neutral |
| Stoch RSI (14) | 20.93 | Neutral |
| CCI (20) | -125.03 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -11.43 | Sell |
| Bollinger %B (20,2) | 0.14 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.01 | Sell |
| Awesome (5,34) | -0.33 | Sell |
| Ultimate (7,14,28) | 24.44 | Buy |
| Momentum (10) | -0.31 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 1.52 | Buy |
| ADX (14) | 30.27 | Sell |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 30.
SMA50 is $2.22 and SMA200 is $3.17, establishing near-term momentum readings. Support is at $1.63 and resistance at $2.33, framing a concise trading band. The thirty-day range spans from $1.26 to $2.13, and annualized volatility is 80%.
These markers suggest limited near-term upside pressure, with price likely oscillating within the defined range while broader fundamentals and sentiment remain neutral.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.55 | $1.58 | $1.95 | 0% | Neutral | |
| $1.22 | $1.58 | $2.17 | 0% | Neutral | |
| $1.12 | $1.50 | $2.17 | -4% | Neutral | |
| $1.05 | $1.45 | $2.16 | -8% | Neutral | |
| $1.32 | $1.88 | $2.89 | +19% | Neutral | |
| $1.40 | $2.05 | $3.24 | +30% | Bullish | |
| $1.36 | $2.04 | $3.30 | +29% | Bullish | |
| $1.37 | $2.09 | $3.46 | +33% | Bullish | |
| $1.18 | $1.84 | $3.11 | +17% | Neutral | |
| $1.24 | $1.97 | $3.39 | +25% | Bullish | |
| $1.52 | $2.67 | $4.94 | +70% | Bullish | |
| $2.27 | $4.75 | $9.76 | +201% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.55 | $1.58 | $1.86 | +0.00% |
| September 2026 | $1.31 | $1.57 | $1.93 | -0.57% |
| October 2026 | $1.28 | $1.54 | $1.92 | -1.98% |
| November 2026 | $1.22 | $1.48 | $1.87 | -3.67% |
| December 2026 | $1.25 | $1.53 | $1.95 | +3.25% |
Click any year to see its month-by-month PLUR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Pluri Inc.'s 2026 outlook centres on $1.58, within a $1.55 to $1.95 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, PLUR could reach as high as $2.17, with a base case around $1.58 and support toward $1.22 — roughly 0% from $1.58. A consolidation phase looks the most probable path here.
Expect PLUR to range from $1.12 to $2.17 through 2028. The $1.50 average target implies a -4% move from current prices. That is -5% versus the projected 2027 average. Price action looks broadly range-bound.
The PLUR price prediction for 2029 points to an average of $1.45 (low $1.05, high $2.16) — a potential decline of -8% on today's $1.58. A consolidation phase looks the most probable path here.
In 2030, PLUR is projected to trade between $1.32 and $2.89, averaging $1.88 — a potential gain of +19% from today's $1.58. That is up +30% on the projected 2029 average. Price action looks broadly range-bound.
Pluri Inc.'s 2031 outlook centres on $2.05, within a $1.40 to $3.24 range. That is up +9% on the projected 2030 average. That marks a +30% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, PLUR could reach as high as $3.30, with a base case around $2.04 and support toward $1.36 — roughly +29% from $1.58. Momentum favours further upside here.
Expect PLUR to range from $1.37 to $3.46 through 2033. The $2.09 average target implies a +33% move from current prices. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The PLUR price prediction for 2034 points to an average of $1.84 (low $1.18, high $3.11) — a potential gain of +17% on today's $1.58. Price action looks broadly range-bound.
In 2035, PLUR is projected to trade between $1.24 and $3.39, averaging $1.97 — a potential gain of +25% from today's $1.58. That is up +7% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Pluri Inc.'s 2040 outlook centres on $2.67, within a $1.52 to $4.94 range. That is up +36% on the projected 2035 average. That marks a +70% change versus current levels. Momentum favours further upside here.
By 2050, PLUR could reach as high as $9.76, with a base case around $4.75 and support toward $2.27 — roughly +201% from $1.58. Buyers look set to stay in control over this stretch.
Investing $1,000 in PLUR today (≈ 634.920635 PLUR) could be worth
$3,014.39
+$2,014.39 (+201%) by 2050 · US Dollar
Based on the average projected PLUR price of $4.75 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PLURwould be worth at today's price.
$1,000 invested in PLUR on Jul 31, 2025 (≈ 189.035918 PLUR) would be worth
$297.73
-$702.27 (-70.2%) today · 0.30× · US Dollar
Based on a PLUR entry price of $5.29 vs. today's $1.58.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.78 | $884.83 | -11.5% |
| 1 month ago | $2.09 | $753.59 | -24.6% |
| 3 months ago | $3.35 | $470.15 | -53.0% |
| 6 months ago | $3.31 | $475.83 | -52.4% |
| 1 year ago | $5.29 | $297.73 | -70.2% |
| All time (5.0y) ago | $25.2 | $62.5 | -93.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PLUR forecast.
Our base-case forecast reaches $3.10 around 2050.
Implied market cap at $3.10: $33.45M
In 2026, the forecast implies a near-flat stance with min $1.63, avg $1.64, max $2.08 and ROI of 0, reflecting a Neutral mood for that year. The outlook shifts into a bullish trajectory from 2031 onward, with 2031 at min $1.43, avg $2.16, max $3.52 and ROI 31.4, followed by 2032 at min $1.38, avg $2.14, max $3.59 and ROI 30.8, and 2033 at min $1.36, avg $2.17, max $3.71 and ROI 32.1.
2034 shows a dip to min $1.16, avg $1.89, max $3.30 with ROI 15.2, before 2035 climbs to min $1.23, avg $2.05, max $3.65 and ROI 25, maintaining a bullish tilt. The forecast accelerates into 2040 with min $1.46, avg $2.74, max $5.29 and ROI 67.1, sustaining bullish sentiment. By 2050, the path strengthens to min $2.27, avg $5.04, max $10.89 and ROI 207.2, with sentiment remaining BULLISH.
These numbers demonstrate an estimated rise in average price and sizable upside potential over the long term, though they are not guarantees and actual results may vary. The outlook reflects the provided year-by-year figures, with bullish momentum materializing in the 2030s and accelerating toward 2050.
Tap a question to reveal the answer.
The 2030 forecast shows min $1.34, avg $1.96, max $3.11 with ROI 19.6% and sentiment NEUTRAL.
Near-term forecasts for 2026 show min $1.63, avg $1.64, max $2.08 with ROI 0 and NEUTRAL sentiment. The outlook becomes bullish from 2031 onward, with higher averages and ROIs through 2050, including a 2050 average of $5.04 and ROI of 207.2%. These are estimates, not guarantees.
Yes. The 2050 forecast shows an average price of $5.04 and a maximum of $10.89, with ROI of 207.2% and bullish sentiment. This underscores potential upside but remains not a guarantee.
The near-term picture is neutral. RSI 14 is 30, with SMA50 at $2.22 and SMA200 at $3.17. Support is $1.63 and resistance is $2.33, and the thirty-day range is $1.26 to $2.13.
Current price is $1.64, market cap is $17.69M, and the rank is 4733.
Pluri Inc. Community Discussion
0Share your Pluri Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.